BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 17716993)

  • 21. Partial correction of murine beta-thalassemia with a gammaretrovirus vector for human gamma-globin.
    Nishino T; Tubb J; Emery DW
    Blood Cells Mol Dis; 2006; 37(1):1-7. PubMed ID: 16814578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective inhibition of beta-globin RNA transcripts by antisense RNA molecules.
    Pace BS; Qian X; Ofori-Acquah SF
    Cell Mol Biol (Noisy-le-grand); 2004 Feb; 50(1):43-51. PubMed ID: 15040426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of human gamma-globin in murine beta-thalassaemia.
    Nishino T; Cao H; Stamatoyannopoulos G; Emery DW
    Br J Haematol; 2006 Jul; 134(1):100-8. PubMed ID: 16803575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Mono- and Bi-Functional GLOBE-Based Vectors for Therapy of β-Thalassemia by
    Koniali L; Flouri C; Kostopoulou MI; Papaioannou NY; Papasavva PL; Naiisseh B; Stephanou C; Demetriadou A; Sitarou M; Christou S; Antoniou MN; Kleanthous M; Patsali P; Lederer CW
    Cells; 2023 Dec; 12(24):. PubMed ID: 38132168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variation in mouse beta globin cysteine content modifies glutathione metabolism: implications for the use of mouse models.
    Hempe JM; Ory-Ascani J; Hsia D
    Exp Biol Med (Maywood); 2007 Mar; 232(3):437-44. PubMed ID: 17327478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemoglobin gene therapy for β-thalassemia.
    Bank A
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1187-201. PubMed ID: 21075288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of alpha-globin gene expression by RNAi.
    Sarakul O; Vattanaviboon P; Wilairat P; Fucharoen S; Abe Y; Muta K
    Biochem Biophys Res Commun; 2008 May; 369(3):935-8. PubMed ID: 18328259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Permanent and panerythroid correction of murine beta thalassemia by multiple lentiviral integration in hematopoietic stem cells.
    Imren S; Payen E; Westerman KA; Pawliuk R; Fabry ME; Eaves CJ; Cavilla B; Wadsworth LD; Beuzard Y; Bouhassira EE; Russell R; London IM; Nagel RL; Leboulch P; Humphries RK
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14380-5. PubMed ID: 12391330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of aberrant splicing of beta-thalassaemia allele (IVS-2-654 C-->T) by antisense RNA expression vector in cultured human erythroid cells.
    Gong L; Gu XF; Chen YD; Ren ZR; Huang SZ; Zeng YT
    Br J Haematol; 2000 Oct; 111(1):351-8. PubMed ID: 11091224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. alpha/beta-Globin mRNA ratio determination by multiplex quantitative real-time reverse transcription-polymerase chain reaction as an indicator of globin gene function.
    Chaisue C; Kitcharoen S; Wilairat P; Jetsrisuparb A; Fucharoen G; Fucharoen S
    Clin Biochem; 2007 Dec; 40(18):1373-7. PubMed ID: 17920577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer.
    Rivella S; May C; Chadburn A; Rivière I; Sadelain M
    Blood; 2003 Apr; 101(8):2932-9. PubMed ID: 12480689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-inheritance of alpha- and beta-thalassaemia in mice ameliorates thalassaemic phenotype.
    Voon HP; Wardan H; Vadolas J
    Blood Cells Mol Dis; 2007; 39(2):184-8. PubMed ID: 17493845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Globin gene transfer for treatment of the beta-thalassemias and sickle cell disease.
    Sadelain M; Rivella S; Lisowski L; Samakoglu S; Rivière I
    Best Pract Res Clin Haematol; 2004 Sep; 17(3):517-34. PubMed ID: 15498721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The degree of phenotypic correction of murine beta -thalassemia intermedia following lentiviral-mediated transfer of a human gamma-globin gene is influenced by chromosomal position effects and vector copy number.
    Persons DA; Hargrove PW; Allay ER; Hanawa H; Nienhuis AW
    Blood; 2003 Mar; 101(6):2175-83. PubMed ID: 12411297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference.
    Samakoglu S; Lisowski L; Budak-Alpdogan T; Usachenko Y; Acuto S; Di Marzo R; Maggio A; Zhu P; Tisdale JF; Rivière I; Sadelain M
    Nat Biotechnol; 2006 Jan; 24(1):89-94. PubMed ID: 16378095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutational spectrum of delta-globin gene in the Portuguese population.
    Morgado A; Picanço I; Gomes S; Miranda A; Coucelo M; Seuanes F; Seixas MT; Romão L; Faustino P
    Eur J Haematol; 2007 Nov; 79(5):422-8. PubMed ID: 17916081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of human beta (s)-globin chains on cellular properties of red cells from beta-thalassemic mice.
    Rubin EM; Kan YW; Mohandas N
    J Clin Invest; 1988 Sep; 82(3):1129-33. PubMed ID: 3417869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Globin gene transfer as a potential treatment for the beta-thalassaemias and sickle cell disease.
    Sadelain M
    Vox Sang; 2004 Jul; 87 Suppl 2():235-42. PubMed ID: 15209924
    [No Abstract]   [Full Text] [Related]  

  • 39. Correction of sickle cell disease in transgenic mouse models by gene therapy.
    Pawliuk R; Westerman KA; Fabry ME; Payen E; Tighe R; Bouhassira EE; Acharya SA; Ellis J; London IM; Eaves CJ; Humphries RK; Beuzard Y; Nagel RL; Leboulch P
    Science; 2001 Dec; 294(5550):2368-71. PubMed ID: 11743206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pathophysiology and molecular genetics of beta thalassemia.
    Forget BG
    Mt Sinai J Med; 1993 Mar; 60(2):95-103. PubMed ID: 8469250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.